CRISPR Therapeutics AG

CRSP · Healthcare · · USD

56.34 USD

+0.00 (0.00%)

● Updated 2026-07-10 18:11 Saudi Time ↻ Refresh

Short-term Mid-term Long-term

Fahodi Score SELL Long-term (Investment)

/ 100

Technical 0

Trend & RS 28

Momentum 47

Fundamental 50

Macro 65

Liquidity 39

Component	Score	Weight
Technical	0.0	10%
Trend & RS	28.1	10%
Momentum	47.2	5%
Fundamental	50.1	40%
Macro	65.2	15%
Liquidity	39.0	20%

Trade Setup

Entry	52.80
Stop Loss	45.99 (12.9%)
Target 1 (1:1)	59.59 (+12.9%)
Target 2 (2:1)	66.39 (+25.8%)

ATR(14)	3.40 (6.4%)
Risk per Share	6.80
Reward:Risk	2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor	Score	Z
Value	73.8	+0.95
Momentum	47.2	-0.11
Quality	40.0	-0.40
Composite	53.6

Quality Scores

Piotroski F-Score 3 /9 — Weak

✗ ✗ ✗ ✗ ✓ ✓ ✗ ✗ ✓

1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover

Altman Z-Score 3.34 — Safe Zone

Distress <1.81Grey 1.81–2.99>2.99 Safe

Valuation vs Peers Undervalued

Metric	Stock	Sector	vs Peers
P/E Ratio	N/A	22.0	Inline
P/B Ratio	3.0	4.0	Below

Comparing against Healthcare median multiples.

Trading at a discount to sector peers — potential value opportunity.

Position Sizing — Kelly Criterion

4.8%

Recommended Size

27.02%

Full Kelly

13.51%

Half Kelly

5.0%

Max Cap (Moderate)

Kelly inputs derived from quant score 43/100. Estimated win rate 53%, avg win 7.6%, avg loss 4.1%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

RECOVERY Regime: RECOVERY (20% confidence) — position size reduced 4%

Signal Summary STRONG SELL

Bullish Signals

Bearish Signals

44.88

RSI(14)

1.28

MACD

Relative Strength (RS) WEAK RS

/ 99

RS Rating

O'Neil filter: <80

RS vs SPY	→ FLAT (-8.8% vs SPY 3M)
RS vs Sector	UNDERPERFORMING (Healthcare)
RS New High	No (4d since high)
Sector Outperformance	-3.3% (3M)

RS Line — stock / SPY (90 bars)

← older newer →

RS vs SPY 50-day SMA of RS

WEAK RS: Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.

Technical Indicators

Indicator	Value	Signal
Rsi	44.88	NEUTRAL
Macd	1.28	BEARISH
Ma Cross	53.28 / 55.49	DEATH CROSS
Trend Short		BELOW SMA50
Trend Long		BELOW SMA200
Bollinger		MIDDLE
Volume	0.46x	LOW

Key Levels

Level	Price
52-Week High	78.48
Bollinger Upper	61.61
SMA(200)	55.49
SMA(50)	53.28
SMA(20)	55.01
Current Price	56.34
Bollinger Lower	48.41
52-Week Low	44.12
ATR(14)	3.4

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

Insufficient data for Wyckoff analysis.

Volume Spread Analysis (last 5 bars)

Date	Signal	Vol	Description
2026-07-06	Normal	1.23x	Normal bar — no special VSA pattern
2026-07-07	Normal	1.0x	Normal bar — no special VSA pattern
2026-07-08	Normal	0.74x	Normal bar — no special VSA pattern
2026-07-09	Normal	0.86x	Normal bar — no special VSA pattern
2026-07-10	Normal	0.46x	Normal bar — no special VSA pattern

Ichimoku Cloud NEUTRAL

Line	Value	Status
Tenkan-sen (9)	58.10	Above Kijun
Kijun-sen (26)	56.23	Base line
Senkou A	57.17	Leading span A
Senkou B	55.19	Leading span B
Cloud	55.19 – 57.17	Bullish (Green)
Price vs Cloud	52.80	Below Cloud
Chikou Span	52.08	Bullish
Alignment Score	3/4	NEUTRAL